A novel compound inhibiting HIV-1 integrase has been identified by means of virtual screening techniques. A small family of structurally related molecules has been synthesized and biologically evaluated with some of the compounds possessing micromolar activity both in enzymatic and cellular assays. (C) 2009 Elsevier Ltd. All rights reserved.
Design, Synthesis, and Biological Activity of Novel 5-((Arylfuran/1<i>H</i>-pyrrol-2-yl)methylene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-4-ones as HIV-1 Fusion Inhibitors Targeting gp41
作者:Shibo Jiang、Srinivasa R. Tala、Hong Lu、Nader E. Abo-Dya、Ilker Avan、Kapil Gyanda、Lu Lu、Alan R. Katritzky、Asim K. Debnath
DOI:10.1021/jm101014v
日期:2011.1.27
5-((arylfuran/1H-pyrrol-2-yl)methylene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-4-ones (12a−o) as HIV-1 entry inhibitors. Compounds 12a−o effectively inhibited infection by both laboratory-adapted and primary HIV-1 strains and blocked HIV-1 mediated cell−cell fusion and gp41 six-helix bundle formation. Molecular docking analyses on two highly active inhibitors, 12b, containing a carboxylic